These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 7007844

  • 41. FM-VP4 Forbes Medi-Tech.
    Burnett JR.
    Curr Opin Investig Drugs; 2003 Sep; 4(9):1120-5. PubMed ID: 14582458
    [Abstract] [Full Text] [Related]

  • 42. Summary of present data from a clinical trial of CI-719.
    Wilkening J, Schwandt P.
    Proc R Soc Med; 1976 Sep; 69 Suppl 2(Suppl 2):90-3. PubMed ID: 1019158
    [No Abstract] [Full Text] [Related]

  • 43. Rationale for and outline of the recommendations of the Working Group on Hypercholesterolemia and Other Dyslipidemias: interim report. Dyslipidemia Working Group of Health Canada.
    Frohlich J, Fodor G, McPherson R, Genest J, Langner N.
    Can J Cardiol; 1998 Apr; 14 Suppl A():17A-21A. PubMed ID: 9594929
    [Abstract] [Full Text] [Related]

  • 44. [Blood coagulation and fibrinolysis systems in patients with hypertriglyceridemia treated with 1,5-dicoffeechinic acid].
    Borodin M, Jurek D, Gregorczyk J, Wójcicki J, Olejak B, Pieczul-Mróz J.
    Przegl Lek; 1982 Sep; 39(8):525-32. PubMed ID: 6897121
    [No Abstract] [Full Text] [Related]

  • 45. [Therapy resistant hyperlipidemia].
    Saltevo J, Kunnamo I.
    Duodecim; 1999 Sep; 115(13):1415,1419. PubMed ID: 11930881
    [No Abstract] [Full Text] [Related]

  • 46. [The effect of hypolipemic treatment on the pharmacokinetics of propranolol].
    Sterna R.
    Ann Acad Med Stetin; 1997 Sep; 43():67-77. PubMed ID: 9471924
    [Abstract] [Full Text] [Related]

  • 47. [An alternative in the therapy of primary hyperlipemias: etofibrate in depot preparations].
    Füsgen I, Summa JD.
    Med Klin; 1980 Nov 07; 75(23):823-5. PubMed ID: 7442597
    [Abstract] [Full Text] [Related]

  • 48. Efficacy of lipid-lowering medications in patients treated with clozapine: a naturalistic study.
    Landry P, Dimitri E, Tessier S, Légaré N.
    J Clin Psychopharmacol; 2008 Jun 07; 28(3):348-9. PubMed ID: 18480696
    [No Abstract] [Full Text] [Related]

  • 49. [A study of the effect of some hypolipidemic substances].
    Synková J.
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1978 Jun 07; 21(4):401-25. PubMed ID: 316922
    [No Abstract] [Full Text] [Related]

  • 50. Efficacy and tolerability of etofibrate and gemfibrozil in combined hyperlipidaemia.
    Wolf HR.
    Drugs Exp Clin Res; 1994 Jun 07; 20(3):109-13. PubMed ID: 7956717
    [Abstract] [Full Text] [Related]

  • 51. [What should be the role of antilipemic agents in the control of hypercholesterolemia in elderly persons?].
    Champoux N, Latour J.
    Union Med Can; 1994 Feb 07; 123(2):91-4. PubMed ID: 8203037
    [No Abstract] [Full Text] [Related]

  • 52. Drugs for lipid disorders.
    Treat Guidel Med Lett; 2003 Aug 07; 1(12):77-82. PubMed ID: 15529095
    [No Abstract] [Full Text] [Related]

  • 53. Dyslipidemia and coronary heart disease: management issues from Indian perspective.
    Gambhir DS, Gambhir JK, Sudha R.
    Indian Heart J; 2000 Aug 07; 52(5):515-6, 617. PubMed ID: 11256772
    [No Abstract] [Full Text] [Related]

  • 54. [Treatment of hyperdyslipidemia in chronic atherosclerotic peripheral obliterating arteriopathies of the lower limbs].
    Bagliani A, Argenteri A, La Rosa A.
    Clin Ter; 1982 Dec 31; 103(6):647-61. PubMed ID: 7160147
    [No Abstract] [Full Text] [Related]

  • 55. [level of 7alpha-hydroxycholesterol in blood plasma as an indicator of cholesterol catabolism in hyperlipidemia and with hypolipidemic therapy].
    Poliakova ED, Ivanova TN, Voshchinnikov EI, Olfer'ev AM, Perova NV.
    Vopr Med Khim; 2000 Dec 31; 46(2):168-75. PubMed ID: 10885038
    [Abstract] [Full Text] [Related]

  • 56. [Multicenter clinical, double blind, and randomized study to assess the effectiveness and safety of binifibrate versus gemfibrozil in type IIa, IIb, and IV hyperlipidemia].
    Corominas Vilardell A, de Oya Otero M, Escobar Jiménez F, Anguera Vila A, Ariño Armengol B.
    An Med Interna; 1993 Nov 31; 10(11):537-41. PubMed ID: 8117868
    [Abstract] [Full Text] [Related]

  • 57. [Clinical study on the antilipemic effect of tiadenol (Eulip)].
    Peduzzi L, Cozzi E.
    Minerva Med; 1983 Feb 18; 74(6):249-54. PubMed ID: 6338419
    [Abstract] [Full Text] [Related]

  • 58. Experience with crystalline niacin as the preferred drug for dyslipidemia in a specialty clinic.
    Rindone JP, Arriola OG.
    Pharmacotherapy; 1997 Feb 18; 17(6):1296-9. PubMed ID: 9399614
    [Abstract] [Full Text] [Related]

  • 59. Clinical research into the hypolipemic and platelet antiaggregant activity of plafibride, Carried out in double-blind conditions and in comparison with clofibrate.
    Palmieri B, Gasparini Casari M, DiBlasio P, Zirilli E.
    Arzneimittelforschung; 1981 Feb 18; 31(10a):1863-6. PubMed ID: 7032534
    [Abstract] [Full Text] [Related]

  • 60. [Low dose clofibrate in the treatment of hypertriglyceridemia in hemodialysis patients (author's transl)].
    Jarillo MD, Coca MC, Díaz Rubio C, Bello I, Gutiérrez-Millet V, Ruilope LM, Rodicio JL, Alvarez Ude F.
    Med Clin (Barc); 1980 Nov 10; 75(8):334-7. PubMed ID: 7442334
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.